about
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Extrahepatic manifestations of chronic hepatitis C virus infectionMicroRNA expression in hepatitis C virus-related malignancies: A brief reviewHepatitis C infection in hemodialysis patients: A reviewVasculitic syndromes in hepatitis C virus: A review.Hepatitis C among Egyptian Patients Referred for Bone Marrow Examination: Seroprevalence and Analysis of Hematological Findings.Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemiaCombined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating CryoglobulinsHepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?New insights into HCV-related rheumatologic disorders: A review.Hepatitis C virus and non-Hodgkin's lymphomas: A minireview.CD81 and hepatitis C virus (HCV) infection.Primary body cavity-based large B-cell lymphoma in an HIV and HHV-8 negative, HCV positive patient: a case report and literature review.Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.Extrahepatic manifestations in chronic hepatitis C virus carriers.Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.Extrahepatic manifestations of HCV: the role of direct acting antivirals.Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells.Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.Spectrum of bone marrow morphologic findings in hepatitis C patients with and without prior liver transplantation.Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection.The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases.Hepatitis C Virus Infection in the Older Patient.Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphomaImpact of Immunochemotherapy-Related Hepatic Toxicity on the Outcome of HCV-Positive Diffuse Large B-Cell Lymphoma Patients
P2860
Q26750997-0F945D5D-73C0-4AD7-8E84-A1AF867648B0Q26767084-1E42EE19-8600-4280-9191-C9100445D469Q26801181-1A7141C7-FBBF-4286-B1A1-409BF26F7F01Q27009100-70734CCC-31A8-440A-8BC3-FEB51A99626CQ30238653-D389CF38-F03B-4382-B30D-B8A2587E826DQ33415225-3E3B95E7-AA8C-4E62-9661-BEDE092E30A9Q34401717-760E6E53-3E8F-4104-9FCB-97B12FE43B45Q34708468-A2DB7E2E-2680-4CA0-9D78-94B30A1342C9Q36194392-0DD7AE81-173A-4891-A59F-9D65BDA2CC4CQ37408923-C7537C2A-4FC3-492D-8C36-041672496992Q37610871-9C4BDC03-91A9-461C-82A8-CBA29C54B27EQ37610899-45F97C16-4EC0-452F-9DA2-5924B0C69F5EQ37611819-52E00C55-81E7-4C43-900C-7F514820BB62Q38215528-EF3EDC55-B469-47F7-A3A1-E7643C4CA5BCQ38298448-5D9AD829-F65B-4D5B-8CDF-4AA36265D44FQ38388423-28DDE3ED-10A2-4197-B714-2D0254977066Q38393228-9572E000-EE5F-44CA-884A-7665A970EB3AQ38684508-259E1F6F-72CF-4D91-A282-247ED5AC13FEQ38792584-F827473D-8008-4756-918D-AFA49C5881B3Q38934954-D629EDD6-D1E1-4D81-9588-1E371099435FQ40528517-7E1D53DF-0081-49A1-8CE2-F136B5A573B0Q40559447-DCDADA3C-D3EE-42D3-8500-78652140BAC4Q40584442-F8D97379-7908-4BDA-AF81-6AD3AF5A7254Q40766567-CF7F8FF2-8B52-4500-9FB7-EB584CC29912Q40774061-DF54D194-782E-43FC-94F0-C13EBC54E6E1Q41053182-F2DA57F5-CC5B-4DF8-A9BF-E2D596CB7A19Q42133572-EB0594AF-A3B9-48EF-8E67-72A14A38F8ECQ42180401-36464EEB-F8C5-413B-A9E3-37F54C66FEE7Q42700930-3B043AE0-3F7C-47DB-98AB-73171F4E8D99Q45325560-9B99E363-4790-41BB-9F08-D44B5535CEF8Q45326066-9AA4920A-EB06-4D41-B4B2-9D8CB12050EFQ57494342-2014F3EA-91BC-4C70-9AAE-3EF89A90C75FQ59052762-310B3747-FC4A-4E2E-AF00-2AEDB92FF07C
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HCV and lymphoproliferation.
@en
type
label
HCV and lymphoproliferation.
@en
prefLabel
HCV and lymphoproliferation.
@en
P2860
P921
P356
P1476
HCV and lymphoproliferation.
@en
P2093
Carlo Giannini
Laura Gragnani
P2860
P304
P356
10.1155/2012/980942
P5008
P577
2012-07-19T00:00:00Z